235 related articles for article (PubMed ID: 14623373)
1. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
Hsiao MC; Lin KJ; Liu CY; Tzen KY; Yen TC
Schizophr Res; 2003 Dec; 65(1):39-46. PubMed ID: 14623373
[TBL] [Abstract][Full Text] [Related]
2. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
[TBL] [Abstract][Full Text] [Related]
3. Decreased dopamine transporter binding in Machado-Joseph disease.
Yen TC; Lu CS; Tzen KY; Wey SP; Chou YH; Weng YH; Kao PF; Ting G
J Nucl Med; 2000 Jun; 41(6):994-8. PubMed ID: 10855623
[TBL] [Abstract][Full Text] [Related]
4. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
[TBL] [Abstract][Full Text] [Related]
5. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
[TBL] [Abstract][Full Text] [Related]
6. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
[TBL] [Abstract][Full Text] [Related]
7. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
Hwang WJ; Yao WJ; Wey SP; Ting G
J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
[TBL] [Abstract][Full Text] [Related]
12. Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women.
Gardiner SA; Morrison MF; Mozley PD; Mozley LH; Brensinger C; Bilker W; Newberg A; Battistini M
Am J Geriatr Psychiatry; 2004; 12(6):621-30. PubMed ID: 15545330
[TBL] [Abstract][Full Text] [Related]
13. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-TRODAT-1 imaging of multiple system atrophy.
Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.
Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Batista IR; Paiva WS; de Andrade DC; Teixeira MJ; de Andrade LA; Barsottini OG; Shih MC; Bressan RA; Ferraz HB
Med Sci Monit; 2014 Aug; 20():1413-8. PubMed ID: 25109468
[TBL] [Abstract][Full Text] [Related]
17. Imaging early-stage corticobasal degeneration with [99mTc]TRODAT-1 SPET.
Lai SC; Weng YH; Yen TC; Tsai CC; Chang HC; Wey SP; Ting G; Lu CS
Nucl Med Commun; 2004 Apr; 25(4):339-45. PubMed ID: 15097807
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in schizophrenia is associated with prefrontal-striatal functional hypoconnectivity and striatal dopaminergic abnormalities.
Yang KC; Yang BH; Liu MN; Liou YJ; Chou YH
J Psychopharmacol; 2024 Jun; 38(6):515-525. PubMed ID: 38853592
[TBL] [Abstract][Full Text] [Related]
19. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia.
Laakso A; Bergman J; Haaparanta M; Vilkman H; Solin O; Syvälahti E; Hietala J
Schizophr Res; 2001 Oct; 52(1-2):115-20. PubMed ID: 11595398
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.
Hesse S; Ballaschke O; Barthel H; Sabri O
Psychiatry Res; 2009 Feb; 171(2):120-8. PubMed ID: 19176281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
